In this issue:
Altered brain maturation associated with risk for bipolar disorder
COMBINE: antipsychotic combination improves acute schizophrenic symptoms
Amygdala overgrowth in ASD starts in the first year of life
Antipsychotic effectiveness decreases after second schizophrenic relapse
Novel biomarker may aid in depression diagnosis and response to therapy
Long-term clozapine use increases the risk for haematological cancer
Could lithium be a prophylactic treatment for dementia?
Adjunct SNT efficacious for treatment-resistant depression
Antidepressants may reduce COVID-19-related mortality
SERENITY II demonstrates rapid calming of bipolar agitation with dexmedetomidine
Please login below to download this issue (PDF)